NDC 0480-4516 – Pemetrexed

Pemetrexed Monohydrate 25 mg/mL · Solution, Concentrate · Intravenous

Human Prescription Drug

Product NDC0480-4516

Product details

Brand name
Pemetrexed
Generic name
Pemetrexed
Labeler
Teva Pharmaceuticals, Inc.
Dosage form
Solution, Concentrate
Route
Intravenous
Marketing category
NDA · NDA208419
Marketed since
June 1, 2022
Listing expires
December 31, 2026
Pharmacologic class
Folate Analog Metabolic Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Pemetrexed →

Package NDC codes (1)

Package NDCDescriptionSince
0480-4516-011 VIAL, SINGLE-DOSE in 1 CARTON (0480-4516-01) / 4 mL in 1 VIAL, SINGLE-DOSEJun 1, 2022

Other Pemetrexed products